Business Description
Nika Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
Description
Nika Pharmaceuticals Inc is a company involved in development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. It has acquired the exclusive rights for production and distribution for the dietary supplements Physiolong and Carotilen, as well as the drug TNG, which has been clinically tested on AIDS patients.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.63 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.29 | |||||
| 9-Day RSI | 58.95 | |||||
| 14-Day RSI | 54.94 | |||||
| 6-1 Month Momentum % | -30.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -104.76 | |||||
| ROIC % | -72.02 | |||||
| ROC (Joel Greenblatt) % | -72.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| EV-to-EBIT | -4245.74 | |||||
| EV-to-EBITDA | -4245.74 | |||||
| EV-to-FCF | -982.28 | |||||
| Earnings Yield (Greenblatt) % | -0.02 | |||||
| FCF Yield % | -0.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NIKA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nika Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 54.94 | ||
| 14-Day ATR ($) | 0.03972 | ||
| 20-Day SMA ($) | 0.403948 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.03 - 13.99 | ||
| Shares Outstanding (Mil) | 1,018.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nika Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nika Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nika Pharmaceuticals Inc Frequently Asked Questions
What is Nika Pharmaceuticals Inc(NIKA)'s stock price today?
The current price of NIKA is $0.50. The 52 week high of NIKA is $13.99 and 52 week low is $0.03.
When is next earnings date of Nika Pharmaceuticals Inc(NIKA)?
The next earnings date of Nika Pharmaceuticals Inc(NIKA) is .
Does Nika Pharmaceuticals Inc(NIKA) pay dividends? If so, how much?
Nika Pharmaceuticals Inc(NIKA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers